- Hlavní
- Analytika
- Zprávy z trhu
- Company news: Moderna (MRNA) quarterly revenues beat analysts’ expectations
Ekonomické zprávy
23.02.2023
Company news: Moderna (MRNA) quarterly revenues beat analysts’ expectations
Moderna (MRNA) reported Q4 FY2022 earnings of $3.61 per share (versus $11.29 per share in Q4 FY2021), may not be comparable to analysts’ consensus estimate of $4.60 per share.
The company’s quarterly revenues amounted to $5.084 bln (-29.5% y/y), beating analysts’ consensus estimate of $5.019 bln.
The company also reiterated approximately $5 bln in sales contracted for delivery in FY2023, and expecting additional sales from key markets.
MRNA fell to $155.50 (-1.69%) in pre-market trading.
Podívejte se také
28.03.2023
Schedule for today, Tuesday, March 28, 2023